3 Tweedy Browne Vertex Pharmaceuticals Trades
Tweedy Browne's position in Vertex Pharmaceuticals is currently worth $28.2 Million. That's 1.31% of their equity portfolio (16th largest holding). Tweedy Browne started to build up the position in Vertex Pharmaceuticals in Q3 2023. Since then they sold 8.31 Thousand shares. The stake costed the investor $23.3 Million, netting the investor a gain of 21% so far.
Avg closing price
Price range
Sold 0.1% shares (-65 shares)
Q1 2024
Avg closing price
$422.74
Price range
$407.69
-
$446.08
Sold 11.0% shares (-8.24 Thousand shares)
Q4 2023
Avg closing price
$369.42
Price range
$343.00
-
$410.68
New holding (+75 Thousand shares)
Q3 2023
Avg closing price
$349.73
Price range
$338.18
-
$362.46
